metformin has been researched along with Experimental Pneumococcal Meningitis in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pneumococcal meningitis is associated with high risk of neurological sequelae such as cognitive impairment and hearing loss." | 5.51 | Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis. ( Grandgirard, D; Le, ND; Leib, SL; Muri, L; Zemp, J, 2019) |
| "Pneumococcal meningitis is associated with high risk of neurological sequelae such as cognitive impairment and hearing loss." | 1.51 | Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis. ( Grandgirard, D; Le, ND; Leib, SL; Muri, L; Zemp, J, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muri, L | 1 |
| Le, ND | 1 |
| Zemp, J | 1 |
| Grandgirard, D | 1 |
| Leib, SL | 1 |
1 other study available for metformin and Experimental Pneumococcal Meningitis
| Article | Year |
|---|---|
Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Ceftriaxone; Cytokines; Disease Models, Animal; Drug Ther | 2019 |